[Treatment protocol for manifestations of persistent COVID]

Persistent COVID is a symptomatic disease involving multiple organs which affects patients who have had COVID-19 and who continue to have symptoms (asthenia, arthralgia, myalgia, headache, dyspnea, cough, chest pain, dysphonia) for more than 4-12 weeks after infection. Its presentation is independent of the severity of the acute COVID-19 phase. It is predominant in middle-aged women. Symptoms frequently fluctuate. It can progress in the form of flare-ups and cannot be explained by an alternative underlying pathology. The incidence of persistent COVID is estimated to be about 10% of those infected. In addition to this symptomatic disease, it is possible that survivors of COVID-19 pneumonia may present with lung sequelae. It is probable that a high number of patients who have had COVID-19 pneumonia will require specialized follow-up by the pulmonology department after overcoming the acute phase. Different algorithms are being established to ensure proper follow-up for these patients.